InflaRx N.V.

IFRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001708688

SEC filings (opens in a new tab)

No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding InflaRx N.V. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of IFRX: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Q1 2025	Change
Holders	30	31	+1
Shares	13.0M	17.5M	+4.52M (+34.8%)
Value	$32.1M	$17.9M	−$14.2M (−44.3%)

New holders (11)

Institutions that held InflaRx N.V. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IFRX in Q1 2025
Institution	Shares	Value	% of portfolio
Silverarc Capital Management, LLC	1,161,567	$1.18M	0.25%
Woodline Partners LP	750,984	$766.0K	0.00%
StemPoint Capital LP	725,019	$739.5K	0.24%
DAFNA Capital Management LLC	450,000	$459.0K	0.13%
XTX Topco Ltd	37,528	$38.3K	0.00%
Quadrature Capital Ltd	13,858	$14.4K	0.00%
Alyeska Investment Group, L.P.	13,538	$13.8K	0.00%
HRT Financial LP	10,724	$10.0K	0.00%
Wells Fargo & Company	2,000	$2.04K	0.00%
Steward Partners Investment Advisory, LLC	550	$561	0.00%
Deutsche Bank AG	200	$204	0.00%

Sold out (10)

Institutions that held InflaRx N.V. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of IFRX in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
UBS Group AG	67,441	$166.6K
Susquehanna International Group, LLP	20,842	$51.5K
Walleye Capital LLC	20,691	$51.1K
Two Sigma Investments, LP	19,716	$48.7K
Two Sigma Securities, LLC	11,461	$28.3K
Schonfeld Strategic Advisors LLC	10,344	$25.5K
Advisor Group Holdings, Inc.	7,500	$18.5K
Bank of America Corp	3,848	$9.51K
JPMorgan Chase & Co	1,058	$2.61K
Federation des caisses Desjardins du Quebec	460	$1.14K